Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
2
NMPA:1
FDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)A Pilot Study of KPL-914 in Recurrent Pericarditis
- First Posted Date
- 2019-06-10
- Last Posted Date
- 2021-05-27
- Lead Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
- Target Recruit Count
- 26
- Registration Number
- NCT03980522
- Locations
- 🇺🇸
Medstar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸Avail Clinical Research, LLC, DeLand, Florida, United States
🇺🇸Mayo Clinic Jacksonville, Jacksonville, Florida, United States
Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis
- First Posted Date
- 2018-11-09
- Last Posted Date
- 2023-09-06
- Lead Sponsor
- Kiniksa Pharmaceuticals (UK), Ltd.
- Target Recruit Count
- 86
- Registration Number
- NCT03737110
- Locations
- 🇺🇸
Cedars-Sinai Medical Institute, Los Angeles, California, United States
🇺🇸Arthritis and Rheumatology of Georgia, Atlanta, Georgia, United States
🇺🇸The Loretto Hospital, Chicago, Illinois, United States
News
No news found